Joseph A. Piechocki

FDA investigator

Appears on 19 documents from 2021 to 2026, most often at sites in India. Most often cites production record review (21 CFR 211.192).

19
Documents on file
5.8
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 110 observations

Activity by year

2021: 3, 2022: 4, 2023: 3, 2024: 5, 2025: 3, 2026: 1

Where

India 8 · Michigan 4 · Indiana 2 · Illinois 1 · Italy 1 · Jordan 1

Is Joseph A. Piechocki coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

19 documents, newest first
FirmOpen
483 EUGIA Pharma Specialities LimitedFeb 27, 2026 · Medchal-Malkajgiri District, India
483 Shilpa Medicare LimitedNov 21, 2025 · Polepally, Jadcherla, India
483 Aurobindo Pharma Ltd.Sep 5, 2025 · Bachupallv, India
483 Somerset Theraoeutics Private LimitedFeb 21, 2025 · Bengaluru, India
483 Future Pak LLCOct 15, 2024 · Wixom, Michigan
483 Granul es India LimitedSep 6, 2024 · Medchal-Malkhajgiri District, India
483 Cipla LimitedJun 21, 2024 · Verna, India

About this profile

What does Joseph A. Piechocki inspect?

Joseph A. Piechocki appears on 19 documents on file covering 19 sites, most often in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Joseph A. Piechocki is dated Feb 27, 2026.